Citi Venture Sheds Sanitas Stake

Citi Venture CapitalInternationalhas sold its 87.2% stake in pharmaceutical companySanitas,AltAssetsreports. The deal values the Lithuanian company at about €365 million.

The sale represents Citi Venture’s fifth successful exit in the generic pharmaceutical space. Sanitas is a branded generic pharmaceutical company focused on specialty therapeutic segments.

Click here for the story fromAltAssets。